CompletedNot Applicable

Clinical Evaluation of Silk'n Glide for Face

17 participantsStarted 2013-09

Plain-language summary

This is a clinical study to determine the efficacy and safety of the Glide, hair removal photo-depilation device, for removing facial hairs. During the first stage, the subjects will perform up to 6 face treatments, two weeks apart. The treatment's safety and efficiency will be evaluated at 4 weeks of after last treatment and at 12 weeks after last treatment.

Who can participate

Age range21 Years – 60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Presence of unwanted hairs on the face
✓. Skin Type I to IV (Fitzpatrick)
✓. Adults older than 21 years of age but not more than 60 years of age.
✓. Must be either post-menopausal or surgically steri-lized, or using a medically acceptable form of birth control (i.e., oral contraceptives, IUD, contraceptive implant, barrier methods with spermicide or absti-nence).
✓. Informed consent agreement by the subject.
✓. Willingness to follow the treatment schedule and post treatment care.

Exclusion criteria

✕. Malignant or pre-malignant pigmented lesions in the area to be treated.
✕. Scarring or infection of the area to be treated.
✕. Known photosensitivity.
✕. Pregnancy or lactating
✕. Subjects with Diabetes (Type I or II).
✕. Presence of a suntan in the area to be treated.
✕. Use of medication known to induce photosensitivity.
✕. Subject is on anticoagulative medication or throm-boembolic condition.

What they're measuring

1. Comparison of Hair Counts Before Treatments to 4 and 12 Weeks Follow up Visits.

Timeframe: 4 weeks and 12 weeks post treatment

Trial details

NCT IDNCT02103608

SponsorHome Skinovations Ltd.

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2014-07

Results submitted2015-03-18

View on ClinicalTrials.gov More Hirsutism trials